Alterations in serum glycosaminoglycan profiles in Graves' patients
-
Katarzyna Komosińska-Vassev
Abstract
Background: Qualitative and quantitative analyses of glycosaminoglycans (GAGs) in serum obtained from Graves' disease (GD) patients without extrathyroidal complications were carried out to provide a clearer understanding of the role of these macromolecules in the disease pathogenesis.
Methods: GAGs were isolated from serum of 17 GD patients before treatment and after attainment of the euthyroid state, as well as from 20 healthy individuals. GAGs were quantified using the hexuronic acid assay and subjected to electrophoretic fractionation.
Results: Increased amounts of total GAGs were found in GD patients. Attainment of euthyroidism led to a decrease in, but not normalization of, total serum GAGs level. Electrophoretic analyses of GAGs before and after treatment identified the presence of chondroitin sulfate (CS), heparan sulfate/heparin (HS/H) and dermatan sulfate (DS) in serum from healthy subjects and GD patients. CS was the predominant serum GAG constituent in all subjects investigated. Enhanced CS levels in both GD patient groups were accompanied by increased structural heterogeneity of these compounds. Normalization of thyroid function did not change CS levels. DS levels in serum of untreated GD patients were elevated in comparison to healthy subjects. Anti-thyroid treatment led to a significant decrease in DS to levels below those in controls. DS in all serum samples investigated displayed a similar structure. HS/H levels in serum of untreated GD patients was seven-fold higher than in healthy subjects. In addition, HS/H in untreated GD patients were characterized by higher structural heterogeneity than those isolated from control subjects and euthyroid GD patients. Anti-thyroid therapy led to a decrease in HS/H concentrations towards normal values.
Conclusions: Our results indicate that in the course of GD, the metabolism of particular types of GAGs is regulated by different mechanisms, including a hyperthyroid state and immunological abnormalities. Furthermore, qualitative and quantitative changes in serum GAGs seem to reflect GD-associated systemic changes in extracellular matrix properties.
References
1. Selleck SB. Proteoglycans and pattern formation. Sugar biochemistry meets developmental genetics. Trends Genet 2000; 16:206–12.10.1016/S0168-9525(00)01997-1Suche in Google Scholar
2. Sugahara K, Kitagawa H. Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr Opin Struct Biol 2000; 10:518–27.10.1016/S0959-440X(00)00125-1Suche in Google Scholar
3. Prydz K, Dalen KT. Synthesis and sorting of proteoglycans. J Cell Sci 2000; 113:193–205.10.1242/jcs.113.2.193Suche in Google Scholar
4. Schwarz NB. Biosynthesis and regulation of expression of proteoglycans. Front Biosci 2000; 5:649–55.10.2741/A540Suche in Google Scholar
5. Dittmann J, Krischek C, Harisch G. Impact of various glycosaminoglycans upon cAMP-dependent protein kinase. Cell Biochem Funct 1999; 17:21–8.10.1002/(SICI)1099-0844(199903)17:1<21::AID-CBF805>3.0.CO;2-0Suche in Google Scholar
6. Bahn RS, Heufelder AH. Orbital connective tissue in endocrine ophthalmopathy. Dev Ophthalmol 1993; 25:44–57.Suche in Google Scholar
7. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 2003; 24:802–35.10.1210/er.2002-0020Suche in Google Scholar
8. Karasek M, Lewinski A. Etiopathogenesis of Graves' disease. Neuroendocrinol Lett 2003; 24:161–6.Suche in Google Scholar
9. Rapoport B, Alsabeh R, Aftergood D, McLachlan SM. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid 2000; 10:685–92.10.1089/10507250050137761Suche in Google Scholar
10. Smith TJ. Fibroblast biology in thyroid diseases. Curr Opin Endocrinol Diabetes 2002; 9:393–400.10.1097/00060793-200210000-00006Suche in Google Scholar
11. Busuttil BE, Frauman AG. Extrathyroidal manifestations of Graves' disease: the thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissues. J Clin Endocrinol Metab 2001; 86:2315–9.Suche in Google Scholar
12. Kahaly G, Hansen C, Beyer J, Winand R. Plasma glycos-aminoglycans in endocrine ophthalmopathy. J Endocrinol Invest 1994; 17:45–50.10.1007/BF03344962Suche in Google Scholar
13. Priestley GC, Aldridge RD, Hurel S. Urinary glycosaminoglycans excretion in Graves' disease. Acta Derm Venereol 1996; 76:368–70.Suche in Google Scholar
14. Hansen C, Fraiture B, Rouhi R, Otto E, Förster G, Kahaly G. HPLC glycosaminoglycan analysis in patients with Graves' disease. Clin Sci 1997; 92:511–7.10.1042/cs0920511Suche in Google Scholar
15. Pappa A, Jackson P, Stone J, Munro P, Fells P, Pennock C, et al. An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy. Eye 1998; 12:237–44.10.1038/eye.1998.57Suche in Google Scholar
16. Kahaly G, Förster G, Hansen C. Glycosaminoglycans in thyroid eye disease. Thyroid 1998; 8:429–32.10.1089/thy.1998.8.429Suche in Google Scholar
17. Hansen C, Rouhi R, Förster G, Kahaly GJ. Increased sulfatation of glycosaminoglycans in Graves' ophthalmopathy. J Clin Endocrinol Metab 1999; 84:1409–13.10.1210/jc.84.4.1409Suche in Google Scholar
18. Shinohara M, Hamasaki Y, Katayama I. Refractory pretibial myxoedema with response to intralesional insulin-like growth factor-1 antagonist (octreotide): downregulation of hyaluronic acid production by the lesional fibroblasts. Br J Dermatol 2000; 143:1083–6.10.1046/j.1365-2133.2000.03850.xSuche in Google Scholar
19. Martins JR, Furlanetto RP, Oliveira LM, Mendes A, Passerotti CC, Chiamolera MI, et al. Comparison of practical methods for urinary glycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 2004; 60:726–33.10.1111/j.1365-2265.2004.02044.xSuche in Google Scholar
20. Volpi N, Cusmano N, Venturelli T. Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma. Biochim Biophys Acta 1995; 1243:49–58.10.1016/0304-4165(94)00123-FSuche in Google Scholar
21. Olczyk K, Głowacki A, Koźma EM. Non-insulin-dependent diabetes mellitus-associated changes in serum glycosaminoglycans. Pathophysiology 1997; 4:121–9.10.1016/S0928-4680(97)00170-3Suche in Google Scholar
22. Blumenkrantz N, Asboe-Hansen G. New method for quantitative determination of uronic acids. Anal Biochem 1973; 54:484–9.10.1016/0003-2697(73)90377-1Suche in Google Scholar
23. Slim GC, Furneaux RH, Yorke SC. A procedure for analysis of glycosaminoglycans mixtures based on digestion by specific enzymes. Carbohydr Res 1994; 255:285–93.10.1016/S0008-6215(00)90985-6Suche in Google Scholar
24. Lagunoff D, Warren G. Determination of 2-deoxy-2-sulpho-aminohexose content of mucopolysaccharides. Arch Biochem Biophys 1962; 99:396–400.10.1016/0003-9861(62)90285-0Suche in Google Scholar
25. Schott M, Scherbaum WA, Morgenthaler NG. Thyrotropin receptor autoantibodies in Graves' disease. Trends Endocrinol Metab 2005; 16:243–8.10.1016/j.tem.2005.05.009Suche in Google Scholar
26. Wład H, Łącka K. Electrophoretic and enzymatic analysis of glycosaminoglycans in the blood serum of patients with hyperthyroidism [in Polish]. Pol Tyg Lek 1989; 4:746–8.Suche in Google Scholar
27. Shishiba Y, Yanagishita M, Hascall V, Takeuchi Y, Yokoi N. Characterization of proteoglycans synthesized by rat thyroid cells in culture and their response to thyroid-stimulating hormone. J Biol Chem 1988; 263:1745–54.10.1016/S0021-9258(19)77939-3Suche in Google Scholar
28. Fratzl-Zelman N, Hörandner H, Leugmayr E, Varga F, Ellinger A, Erlee MP, et al. Effects of triiodothyronine on morphology of cells and matrix, the localization of alkaline phosphatase, and the frequency of apoptosis in long-term cultures of MC3T3-E1 cells. Bone 1997; 20:225–36.10.1016/S8756-3282(96)00367-5Suche in Google Scholar
29. Smith TJ, Bahn RS, Gorman CA. Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts. J Clin Endocrinol Metab 1989; 69:1019–23.10.1210/jcem-69-5-1019Suche in Google Scholar
30. Koresse H, Glössl J. Glycosaminoglycan degradation. Adv Enzymol Relat Areas Mol Biol 1987; 60:217–311.10.1002/9780470123065.ch4Suche in Google Scholar
31. Moseley R, Waddington RJ, Embery G. Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim Biophys Acta 1997; 31:221–31.10.1016/S0925-4439(97)00083-5Suche in Google Scholar
32. Hijova E. Matrix metalloproteinases: their biological functions and clinical implications. Bratisl Lek Listy 2005; 106:127–32.Suche in Google Scholar
33. Porter S, Clark IM, Kevorkian L, Edwards RD. The ADAMTS metalloproteinases. Biochem J 2005; 15:15–27.10.1042/BJ20040424Suche in Google Scholar
34. Makihira S, Yan W, Murakami H, Furukawa M, Kawai T, Nikawa H, et al. Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage. Endocrinology 2003; 144:2480–8.10.1210/en.2002-220746Suche in Google Scholar
35. Pereira RC, Jorgetti V, Canalis E. Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. Am J Physiol 1999; 277:E496–E504.10.1152/ajpendo.1999.277.3.E496Suche in Google Scholar
36. Komosińska-Vassev K, Olczyk K, Koźma EM, Winsz-Szczotka K, Olczyk P, Wisowski G. Graves' disease-associated changes in the serum lysosomal glycosidases activity and the glycosaminoglycan content. Clin Chim Acta 2003; 331:97–102.10.1016/S0009-8981(03)00090-1Suche in Google Scholar
37. Komosińska-Vassev K, Olczyk K, Kucharz EJ, Marcisz CZ, Winsz-Szczotka K. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta 2000; 300:107–17.10.1016/S0009-8981(00)00306-5Suche in Google Scholar
38. Kinsella MG, Bressler SL, Wight TN. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 2004; 14:203–34.10.1615/CritRevEukaryotGeneExpr.v14.i3.40Suche in Google Scholar PubMed
39. Natt N, Bahn RS. Cytokines in the evolution of Graves' ophthalmopathy. Autoimmunity 1997; 26:129–36.10.3109/08916939709003857Suche in Google Scholar PubMed
40. Bahn RS. Cytokines in thyroid eye disease: potential for anticytokine therapy. Thyroid 1998; 8:415–8.10.1089/thy.1998.8.415Suche in Google Scholar PubMed
41. Wang L, Teng W, Shan Z. Effect of INF-gamma, IL-4 on proliferation and synthesis of hyaluronic acid and collagen in cultured human retroorbital fibroblasts in vitro. Chin Med J (Engl) 2000; 113:907–10.Suche in Google Scholar
42. Smith TJ. Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 2002; 12:197–203.10.1089/105072502753600133Suche in Google Scholar PubMed
43. Bednarczuk T, Hiromatsu Y, Wall JR, Nauman J. T cell mediated immunity in thyroid-associated ophthalmopathy. Thyroid 2002; 12:209–15.10.1089/105072502753600151Suche in Google Scholar PubMed
©2006 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- CCLM: Expanding the science worldwide
- Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening
- Immunochemical quantification of free immunoglobulin light chains from an analytical perspective
- De novo deletion removes a conserved motif in the C-terminus of ABCA4 and results in cone-rod dystrophy
- Molecular detection of squamous cell carcinoma antigen transcripts in peripheral blood of cancer patients
- Influence of human haptoglobin polymorphism on oxidative stress induced by free hemoglobin on red blood cells
- Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia
- Association of high-sensitive C-reactive protein with advanced stage β-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus
- A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients
- National survey on the execution of the oral glucose tolerance test (OGTT) in a representative cohort of Italian laboratories
- The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in β-thalassemia/Hb E
- Alterations in serum glycosaminoglycan profiles in Graves' patients
- Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients
- Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human sera
- Utilizing ultrafiltration to remove alkaline phosphatase from clinical analyzer water
- Measurement of serum monoclonal components: comparison between densitometry and capillary zone electrophoresis
- Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases?
- Reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, and mean sphered cell volume in elite athletes: reference values and comparison with the general population
- Serum homocysteine levels and paraoxonase 1 activity in preschool aged children in Greece
- The effects of adrenocorticotrophic hormone and cortisol on homocysteine and vitamin B concentrations
- Plasma, salivary and urinary cotinine in non-smoker Italian women exposed and unexposed to environmental tobacco smoking (SEASD study)
- Cut-off values for total serum immunoglobulin E between non-atopic and atopic children in north-west Croatia
- Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures
- Evaluation of serum levels of p53 in hepatocellular carcinoma in Egypt
- Insufficient filling of vacuum tubes as a cause of microhemolysis and elevated serum lactate dehydrogenase levels. Use of a data-mining technique in evaluation of questionable laboratory test results
- Evaluation of three different specimen types (serum, plasma lithium heparin and serum gel separator) for analysis of certain analytes: clinical significance of differences in results and efficiency in use
- Comparative evaluation of a new immunoradiometric assay for corticotropin
- Mast cells in atherosclerosis as a source of the cytokine RANKL
- Falsely increased total serum protein due to dextran interference
Artikel in diesem Heft
- CCLM: Expanding the science worldwide
- Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening
- Immunochemical quantification of free immunoglobulin light chains from an analytical perspective
- De novo deletion removes a conserved motif in the C-terminus of ABCA4 and results in cone-rod dystrophy
- Molecular detection of squamous cell carcinoma antigen transcripts in peripheral blood of cancer patients
- Influence of human haptoglobin polymorphism on oxidative stress induced by free hemoglobin on red blood cells
- Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia
- Association of high-sensitive C-reactive protein with advanced stage β-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus
- A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients
- National survey on the execution of the oral glucose tolerance test (OGTT) in a representative cohort of Italian laboratories
- The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in β-thalassemia/Hb E
- Alterations in serum glycosaminoglycan profiles in Graves' patients
- Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients
- Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human sera
- Utilizing ultrafiltration to remove alkaline phosphatase from clinical analyzer water
- Measurement of serum monoclonal components: comparison between densitometry and capillary zone electrophoresis
- Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases?
- Reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, and mean sphered cell volume in elite athletes: reference values and comparison with the general population
- Serum homocysteine levels and paraoxonase 1 activity in preschool aged children in Greece
- The effects of adrenocorticotrophic hormone and cortisol on homocysteine and vitamin B concentrations
- Plasma, salivary and urinary cotinine in non-smoker Italian women exposed and unexposed to environmental tobacco smoking (SEASD study)
- Cut-off values for total serum immunoglobulin E between non-atopic and atopic children in north-west Croatia
- Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures
- Evaluation of serum levels of p53 in hepatocellular carcinoma in Egypt
- Insufficient filling of vacuum tubes as a cause of microhemolysis and elevated serum lactate dehydrogenase levels. Use of a data-mining technique in evaluation of questionable laboratory test results
- Evaluation of three different specimen types (serum, plasma lithium heparin and serum gel separator) for analysis of certain analytes: clinical significance of differences in results and efficiency in use
- Comparative evaluation of a new immunoradiometric assay for corticotropin
- Mast cells in atherosclerosis as a source of the cytokine RANKL
- Falsely increased total serum protein due to dextran interference
